Nearly two and a half years ago, Google (Menlo Park, California) revealed its intention to become a dominant player in the wearable technologies market with the introduction of Project Glass – an effort that would start the path to the creation of Google Glass. Leading off with the mission statement – "We think technology should work for you – to be there when you need it and get out of your way when you don't," the company focused on changing the paradigm of how the public could conceivably access data.

Orthofix (Lewisville, Texas) is reporting the launch of a large-scale clinical study to evaluate the use of pulsed electromagnetic fields (PEMF) technology to see if the therapy can improve osteogenesis (bone growth) in Type II odontoid fractures. More specifically, the study will examine the safety and effectiveness of PEMF treatment with the Orthofix Cervical-Stim device as an adjunct to standard immobilization with a rigid collar.

A newly launched company is trying its hand at eliminating unnecessary hospitalizations and better insight on patient deterioration. Sentrian (Aliso Viejo, California) is developing the Remote Intelligence Patient Platform – a software application that could quite possibly help garner greater insight on the health of the patient.

Shockwave Medical (Fremont, California), a company that specializes in the treatment of peripheral and coronary vascular disease, reported positive clinical results from DISRUPT PAD, a single-arm multi-center study evaluating the safety and utility of Lithoplasty balloon catheters for the treatment of peripheral artery disease, at the Vascular Interventional Advances (VIVA) Annual Conference in Las Vegas.